{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T23:57:28Z","timestamp":1770076648549,"version":"3.49.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1016\/j.amjcard.2005.12.015","type":"journal-article","created":{"date-parts":[[2006,2,10]],"date-time":"2006-02-10T12:29:39Z","timestamp":1139574579000},"page":"S82-S85","source":"Crossref","is-referenced-by-count":44,"special_numbering":"S1","title":["An Assessment of Statin Safety by Nephrologists"],"prefix":"10.1016","volume":"97","author":[{"given":"Bertram L.","family":"Kasiske","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Wanner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. Charles","family":"O\u2019Neill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2005.12.015_bib1","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1093\/ndt\/gfh474","article-title":"Renal tubular toxicity of HMG-CoA reductase inhibitors","volume":"19","author":"van Zyk-Smit","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.amjcard.2005.12.015_bib2","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/j.1365-2125.2003.02060.x","article-title":"Meta-analysis of large randomized controlled trials to evaluate the impact of statins on cardiovascular outcomes","volume":"15","author":"Cheung","year":"2004","journal-title":"Br J Clin Pharmacol"},{"issue":"suppl 8A","key":"10.1016\/j.amjcard.2005.12.015_bib3","doi-asserted-by":"crossref","first-page":"44C","DOI":"10.1016\/j.amjcard.2005.12.009","article-title":"Statin safety","volume":"97","author":"Jacobson","year":"2006","journal-title":"Am J Cardiol"},{"issue":"suppl 8A","key":"10.1016\/j.amjcard.2005.12.015_bib4","doi-asserted-by":"crossref","first-page":"52C","DOI":"10.1016\/j.amjcard.2005.12.010","article-title":"Statin safety","volume":"97","author":"Law","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2005.12.015_bib5","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/0140-6736(90)93164-K","article-title":"Proteinuria as complication of simvastatin treatment [letter]","volume":"336","author":"Deslypere","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2005.12.015_bib6","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1097\/01.ASN.0000136778.32499.05","article-title":"Inhibitors of HMG-CoA reductase reduce receptor-mediated endocytosis in human kidney proximal tubular cells","volume":"15","author":"Verhulst","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.amjcard.2005.12.015_bib7","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1097\/01.ASN.0000138236.82706.EE","article-title":"Inhibitors of 3-hydroxy-3-methylglutaryl-CoA reductase reduce receptor-mediated endocytosis in opossum kidney cells","volume":"15","author":"Sidaway","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.amjcard.2005.12.015_bib8","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1046\/j.1523-1755.2001.00487.x","article-title":"The effect of lipid reduction on renal disease progression","volume":"59","author":"Fried","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.amjcard.2005.12.015_bib9","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1053\/ajkd.2003.50140","article-title":"A controlled, prospective study of the effects of atorvastatin on proteinuria and progression of kidney disease","volume":"41","author":"Bianchi","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.amjcard.2005.12.015_bib10","doi-asserted-by":"crossref","first-page":"85","DOI":"10.5414\/CNP60085","article-title":"Effect of fluvastatin and dipyridamole on proteinuria and renal function in childhood IgA nephropathy with mild histological findings and moderate proteinuria","volume":"60","author":"Kano","year":"2003","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.amjcard.2005.12.015_bib11","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1097\/01.ASN.0000068461.45784.2F","article-title":"Effect of pravastatin on loss of renal function in people with moderate chronic renal insufficiency and cardiovascular disease","volume":"14","author":"Tonelli","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.amjcard.2005.12.015_bib12","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1136\/jcp.2003.012989","article-title":"The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease","volume":"57","author":"Athyros","year":"2004","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.amjcard.2005.12.015_bib13","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000077704","article-title":"Rosuvastatin-induced arrest in progression of renal disease","volume":"102","author":"Vidt","year":"2004","journal-title":"Cardiology"},{"issue":"suppl 3","key":"10.1016\/j.amjcard.2005.12.015_bib14","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for managing dyslipidemias in chronic kidney disease","volume":"41","author":"Kasiske","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.amjcard.2005.12.015_bib15","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/S0140-6736(03)13638-0","article-title":"Effect of fluvastatin on cardiac outcomes in renal transplant recipients","volume":"361","author":"Holdaas","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2005.12.015_bib16","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa043545","article-title":"Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis","volume":"353","author":"Wanner","year":"2005","journal-title":"N Engl J Med"},{"issue":"suppl 84S","key":"10.1016\/j.amjcard.2005.12.015_bib17","doi-asserted-by":"crossref","first-page":"S204","DOI":"10.1046\/j.1523-1755.63.s84.10.x","article-title":"Why do we need a statin trial in hemodialysis patients?","volume":"63","author":"Fellstrom","year":"2003","journal-title":"Kidney Int Suppl"},{"issue":"suppl 84S","key":"10.1016\/j.amjcard.2005.12.015_bib18","doi-asserted-by":"crossref","first-page":"S207","DOI":"10.1046\/j.1523-1755.63.s84.4.x","article-title":"Study of Heart and Renal Protection (SHARP)","volume":"63","author":"Baigent","year":"2003","journal-title":"Kidney Int Suppl"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000291490502148X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000291490502148X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,18]],"date-time":"2019-01-18T14:53:06Z","timestamp":1547823186000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000291490502148X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":18,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["S000291490502148X"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2005.12.015","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]}}}